Methods for treating cancer

Details for Australian Patent Application No. 2008236997 (hide)

Owner Myriad Pharmaceuticals, Inc.

Inventors Willardsen, Adam; Pleiman, Chris; Laughlin, Mark; Anderson, Mark B.

Agent Peter Maxwell & Associates

Pub. Number AU-A-2008236997

PCT Pub. Number WO2008/124826

Priority 60/910,944 10.04.07 US

Filing date 10 April 2008

Wipo publication date 16 October 2008

International Classifications

C07D 239/72 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/124826 Priority application(s): WO2008/124826

15 December 2011 Alteration of Name

  The name of the applicant has been altered to Myrexis, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008237017-Droplet dispensing device and methods

2008236996-An antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications